[go: up one dir, main page]

AU2001235000A1 - Drug metabolizing enzymes - Google Patents

Drug metabolizing enzymes

Info

Publication number
AU2001235000A1
AU2001235000A1 AU2001235000A AU3500001A AU2001235000A1 AU 2001235000 A1 AU2001235000 A1 AU 2001235000A1 AU 2001235000 A AU2001235000 A AU 2001235000A AU 3500001 A AU3500001 A AU 3500001A AU 2001235000 A1 AU2001235000 A1 AU 2001235000A1
Authority
AU
Australia
Prior art keywords
metabolizing enzymes
drug metabolizing
drug
enzymes
metabolizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001235000A
Inventor
Yalda Azimzai
Olga Bandman
Mariah R. Baughn
Ameena R. Gandhi
Preeti Lal
Jennifer L. Policky
Huijun Z. Ring
Leo L. Shih
Y. Tom Tang
Junming Yang
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2001235000A1 publication Critical patent/AU2001235000A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001235000A 2000-02-11 2001-02-08 Drug metabolizing enzymes Abandoned AU2001235000A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US18185600P 2000-02-11 2000-02-11
US60181856 2000-02-11
US18368400P 2000-02-17 2000-02-17
US60183684 2000-02-17
US18514100P 2000-02-25 2000-02-25
US60185141 2000-02-25
US18681800P 2000-03-03 2000-03-03
US60186818 2000-03-03
US18834500P 2000-03-09 2000-03-09
US60188345 2000-03-09
US18999700P 2000-03-17 2000-03-17
US60189997 2000-03-17
PCT/US2001/004423 WO2001059127A2 (en) 2000-02-11 2001-02-08 Drug metabolizing enzymes

Publications (1)

Publication Number Publication Date
AU2001235000A1 true AU2001235000A1 (en) 2001-08-20

Family

ID=27558717

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001235000A Abandoned AU2001235000A1 (en) 2000-02-11 2001-02-08 Drug metabolizing enzymes

Country Status (5)

Country Link
EP (1) EP1254236A2 (en)
JP (1) JP2003522528A (en)
AU (1) AU2001235000A1 (en)
CA (1) CA2399873A1 (en)
WO (1) WO2001059127A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1328151A4 (en) * 1999-04-29 2004-06-16 Univ Tennessee Res Corp ISOLATED NUCLEIC ACIDS OF THE P-HYDE FAMILY, P-HYDE PROTEINS AND METHOD FOR PRODUCING SENSITIVITY TO THE INDUCTION OF CELL DEATH IN CANCER
US6835812B1 (en) 1999-04-29 2004-12-28 University Of Tennessee Research Corporation Human p-Hyde proteins
US20020022254A1 (en) * 2000-07-28 2002-02-21 Karl Guegler Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
US20060063230A1 (en) 2000-12-27 2006-03-23 Roman Naworth Sulfatases and methods of use thereof
US20030148920A1 (en) * 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
GB0202748D0 (en) * 2002-02-06 2002-03-27 Impharmatica Ltd Protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103756T3 (en) * 1990-06-22 1997-10-01 Hoffmann La Roche DETECTION OF INEFFECTIVE PHARMACEUTICAL METABOLIZERS.
GB9225845D0 (en) * 1992-12-10 1993-02-03 Nickerson Biocem Ltd Modified plants
US6136964A (en) * 1996-03-19 2000-10-24 Cell Therapeutics, Inc. Mammalian lysophosphatidic acid acyltransferase
AU7600098A (en) * 1997-05-27 1998-12-30 Icos Corporation Novel lysophosphatidic acid acyltransferase
US5888793A (en) * 1998-02-25 1999-03-30 Incyte Pharmaceuticals, Inc. Human lysophosphatidic acid acyltransferase

Also Published As

Publication number Publication date
EP1254236A2 (en) 2002-11-06
WO2001059127A2 (en) 2001-08-16
CA2399873A1 (en) 2001-08-16
WO2001059127A3 (en) 2002-02-07
JP2003522528A (en) 2003-07-29

Similar Documents

Publication Publication Date Title
AUPQ899700A0 (en) Probiotic recolonisation therapy
AU2001279134A1 (en) Nucleotide incorporating enzymes
AU7961401A (en) Subtilase enzymes
AU2002357860A1 (en) Enzymes
AU1878601A (en) Enzyme
AU2002220553A1 (en) Bioreactor
GB0006733D0 (en) Enzyme
AU2001227900A1 (en) Drug metabolizing enzymes
AU2001274981A1 (en) Drug metabolizing enzymes
AU2001270303A1 (en) Drug metabolizing enzymes
AU2001262702A1 (en) Coenzyme derivatives and enzymes appropriate therefor
EP1572877A3 (en) Drug metabolizing enzymes
AU2002347778A1 (en) Enzymes
AU2001255324A1 (en) Drug metabolizing enzymes
AU2001235000A1 (en) Drug metabolizing enzymes
AU2002210379A1 (en) Subtilase variants
AU2001232244A1 (en) Drug comprising combination
AU2001264247A1 (en) GASC1 gene
AU2001278154A1 (en) Drug metabolizing enzymes
AU2001247444A1 (en) Erbeta-mediated gene expression
AUPQ749100A0 (en) New epilespy gene
AU2001237592A1 (en) Enzymes and uses relating thereto
AU2001285743A1 (en) Adipose-related gene
AU2001292330A1 (en) Drying-resistant yeast
AU2001294823A1 (en) Hydrolases